Castle Published in PM360 on Groundbreaking MSL Salary Report

February 16, 2015 · Leave a comment

In January 2015, the Medical Science Liaison Society released a first-of-its-kind global salary and compensation report which included feedback from more than 1,350 MSLs, MSL Managers, medical affairs executives from 65 countries. PM360, the premier publication for marketing decision makers in the pharmaceutical, biotech, and medical device industries called upon Thought Leader Select’s Director of Global Marketing and Client Relations, Brian Castle, to summarize the findings of this pioneering study:

pm360 article sm

Smithwick Authors Article for Physicians Practice Magazine

February 6, 2015 · Leave a comment

To assist healthcare professionals dealing with challenges surrounding the Sunshine Act, Physicians Practice magazine turned to Thought Leader Select Vice President, Kristen Smithwick, for counsel. Smithwick compiled step-by-step recommendations on navigating the new regulations to enable the continued collaboration between physicians and industry:

Physician-Industry Collaboration and the Sunshine Act | Physicia

Landmark Global Salary Report Released by Thought Leader Select Partner, Medical Science Liaison Society

January 29, 2015 · Leave a comment

Survey Includes Over 1,350 MSLs, MSL Managers, Medical Affairs Executives from 65 Countries


The Medical Science Liaison Society (MSL Society), the world’s first and only non-profit organization dedicated to the advancement of the medical science liaison (MSL) role in the pharmaceutical and other healthcare industries, announces the release of its first annual global salary and compensation report for the MSL profession.

The MSL Salary and Compensation Report was supported by society partner, Thought Leader Select, a US-based firm that works with commercial and medical affairs teams in life sciences companies to optimize their relationships and collaborations with key opinion leaders (KOLs) in medicine. The MSL Society surveyed more than 1,350 MSLs, MSL managers and Medical Affairs executives from 65 countries.

Among other findings, the average starting salary of an MSL in the U.S. is $121,712, while the average salary of an MSL with over fifteen years of experience in the U.S. is $168,429.

The full findings are complied using an infographic-style report of more than 250 pages of data representing six distinct regions: the United States, North America, South America, Europe, Africa/Middle East, and Asia/Pacific. The report includes detailed breakdowns across salary ranges, salary by degree type (MD, PhD, PharmD), salary by role (MSL, Senior MSL), salary by years of experience, and salary by company type (large pharma, small pharma, startup biotech).

“We ... read more »

Ethical Corp Magazine: Paul Meade Weighs in on Transparency

December 29, 2014 · Leave a comment

In this month’s issue, Ethical Corporation Magazine debates whether increased transparency in healthcare is truly the best way to compel ethical behavior among industry players. In need of input from an expert on public health ethics, the publication asked Thought Leader Select’s Paul Meade to share his thoughts on the implications of expanding accountability in the pharmaceutical industry.

 

 

Pharma Compliance Monitor Solicits Industry Advice from Meade

November 11, 2014 · Leave a comment

With the future of medical innovation hanging in the balance, confusion surrounding the Sunshine Act has left those in the pharmaceutical industry in need of insight as they decide how best to collaborate with physicians.  To address these concerns, the Pharmaceutical Compliance Monitor (PCM), a publication spotlighting regulatory and compliance news and developments for the pharmaceutical and biotechnology communities, sought the expertise of Thought Leader Select’s Paul Meade:

 

Triangle Business Journal Selects Meade for Guest Column

November 10, 2014 · Leave a comment

In the wake of the Sunshine Act’s Open Payments database launch, press detailing payments made to doctors by the pharma and medical device industries is fueling speculation about the negative impact this development could have on industry.

Given the Raleigh-Durham area’s top medical centers and concentration of pharmaceutical/device manufacturers, the release of this information could have a lot of implications on the Triangle’s economy, in particular. As the region’s leading source of business news, the Triangle Business Journal turned to Thought Leader Select’s Paul Meade for his expert insight into these concerns:

TAGS:                                                   

Meade Featured as Sunshine Disclosure Expert

October 16, 2014 · Leave a comment

As disclosures of life science industry payments to healthcare professionals continue with rollouts such as the Centers for Medicare and Medicaid Services’ Open Payments Database in late September, Thought Leader Select’s Paul Meade has been a sought-after expert on the impact of these disclosures on industry collaborations with key opinion leaders in medicine.

Meade, the company’s founder and president, spent 25 years leading brand and strategy teams at global drug manufacturers Merck and GlaxoSmithKline and understands the critical importance that key opinion leader interactions bring to the table in both medical affairs and commercialization efforts for pharmaceutical, biotechnology, and medical device companies.

In the attached FDA News story (subscription required), Meade provided context for greater understanding on the recently-released CMS database numbers totaling some $3.5 billion in payments to physicians.  He encouraged the media and public to dig deeper in order see how honoraria and especially travel and meal costs can quickly add up as companies engage leading physicians on a broad range of scientific activities that drive product development and peer awareness that ultimately improve patient outcomes and quality of life measures over time.

For more information or media inquiries, please contact Brian Castle, Director of ... read more »

TAGS:                                                     

Thought Leader Select Customizes KOL Identification Methodologies in Support of Global Diabetes Initiatives

August 18, 2014 · Leave a comment

By Brian Castle

Throughout most of 2014, Thought Leader Select has been privileged to work with a top-five global biopharmaceutical giant in support of its diabetes portfolio in across the globe. 

For this particular engagement, across several countries with cultural and language differences, stakeholders within the client company needed a customized approach.  The chosen approach must leave no doubt within the organization—nor among the external group of key opinion leaders (KOLs) chosen for engagement—that the company had taken a measured path to selecting the right members of the medical community for outreach and support in diabetes.

From our work with more than 50 leading biotechnology, pharmaceutical, and medical device companies over the last decade, we know the importance of satisfying competing visions for KOL selection.  Some prefer an objective methodology based on research by subject matter experts, while others prefer a guided process of nominations by trained professionals, often former practitioners themselves, tasked with outreach to leaders in the medical community.

We also know the importance of the respect that the KOLs themselves have for the company and its selection process.  KOLs most obviously and critically form their judgments about companies through their personal interactions with industry representatives at every level, from commercial executives at regional and global headquarters to more locally-based ... read more »

TAGS:                                       

Thought Leader Select Supports Top Biopharma with KOL Strategies in Head and Neck Cancer

July 1, 2014 · Leave a comment

July 1, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries, has initiated new research and consulting work in support of a top global biopharmaceutical company’s developing portfolio of treatments for head and neck cancer.

The firm’s latest engagement in support of the collaborative work among life sciences companies and leaders in the medical community consists of detailed research and engagement planning for work with experts at Canadian centers of excellence in head and neck cancer. The client company, known worldwide as a leader in the development of prescription medicines, has engaged Thought Leader Select for more support in multiple therapeutic areas and disease states, including key opinion leader and centers of excellence identification and profiling in multiple cancers, diabetes, and infectious diseases.

According to the National Cancer Institute at the National Institutes of Health, head and neck cancers originate in the squamous cells that line the moist areas of the head and neck.  Alcohol and tobacco use, as well as exposure to human papilloma virus, are important risk factors related to the development of many incidences of head and neck cancer.  Physicians diagnose nearly half a million new cases of head and neck cancers worldwide each year.

Thought Leader Select, headquartered ... read more »

TAGS:                                           

Thought Leader Select’s Meade to Address ExL Pharma KOL Conference

June 17, 2014 · Leave a comment

Thought Leader Select continues with a busy summer schedule of conference sponsorships, with the company’s support of ExL Pharma’s Fifth KOL Relationship Summit in Philadelphia.  Paul Meade, founder and President of Thought Leader Select, will address attendees at one of the must-attend events for American life sciences companies, coming on the heels of the company’s successful sponsorship of the Canadian Healthcare Licensing Association’s Summer Meeting and the Medical Science Liaison Society’s Global Conference in Boston.

The conference, geared to medical affairs and marketing professionals tasked with outreach to and collaboration with key opinion leaders (KOLs) in the medical community, will take place June 24-25 at the Hyatt Bellevue in the Center City area of downtown Philadelphia.  The Summit will feature a variety of speakers from companies within the life sciences industry, as well as consultants from the world of KOL strategy, CRM software, medical communications, and digital engagement platforms for healthcare.

Thought Leader Select’s Meade will lead an afternoon session on day one of the event, speaking on the topic, “Can Industry Still Work Effectively with KOLs?” During his talk, Meade will illustrate many of the challenges facing both industry representatives and thought leaders in the medical community, including transparency, scrutiny, and ... read more »

TAGS:                               

Older posts »